The portfolio is positioned for Fed tapering and for a global economic recovery.
We've seen a tectonic shift in sentiment and trend.
We don't believe its strong international growth potential is priced into the shares.
Trailing orders for November beat expectations, and we will look to increase our holding.
Earnings and revenue both beat consensus, and the company raises guidance.
A catalyst is needed to break the stalemate between the Fed's mild tapering and the economy's slow growth, yet optimism may be warranted.
We'll add 200 shares to Nike, which is down after in-line earnings.
Still soft, but generally in line with consensus.
We like the company's restructuring, and the stock is near our cost basis.
The company reiterates its outlook and its focus on core industrial operations.